Post-injury epilepsy (PIE) is a common complication following brain insults, including ischemic, and traumatic brain injuries. At present, there are no means to identify the patients at risk to develop PIE or to prevent its development. Seizures can occur months or years after the insult, do not respond to anti-seizure medications in over third of the patients, and are often associated with significant neuropsychiatric morbidities. We have previously established the critical role of blood-brain barrier dysfunction in PIE, demonstrating that exposure of brain tissue to extravasated serum albumin induces activation of inflammatory transforming growth factor beta (TGF-β) signaling in astrocytes and eventually seizures. However, the link between the acute astrocytic inflammatory responses and reorganization of neural networks that underlie recurrent spontaneous seizures remains unknown. Here we demonstrate in vitro and in vivo that activation of the astrocytic ALK5/TGF-β-pathway induces excitatory, but not inhibitory, synaptogenesis that precedes the appearance of seizures. Moreover, we show that treatment with SJN2511, a specific ALK5/TGF-β inhibitor, prevents synaptogenesis and epilepsy. Our findings point to astrocyte-mediated synaptogenesis as a key epileptogenic process and highlight the manipulation of the TGF-β-pathway as a potential strategy for the prevention of PIE. © 2015 Elsevier Inc. All rights reserved.
Introduction
Traumatic, ischemic, and infectious brain injuries often initiate a cascade of epileptogenic events, ultimately leading to post-injury epilepsy (PIE) after a latent period of months to years. Accumulating evidence suggests a key role of post-injury dysfunction of the blood-brain barrier (BBB) in the development of PIE: BBB dysfunction is a well-documented finding in patients following brain trauma (occurring within hours of the event and often persisting for days to weeks; for a review, see Abbott and Friedman, 2012; Cunningham et al., 2005; Rosenberg, 2012; Shlosberg et al., 2010) and is more frequent in post-traumatic patients with epilepsy (Raabe et al., 2012; Schmitz et al., 2013; Tomkins et al., 2008) . In experimental animals, BBB dysfunction was associated with increased propensity for symptomatic seizures and the development of epilepsy (Friedman et al., 2009; Frigerio et al., 2012; Marchi et al., 2007; Seiffert et al., 2004; Van Vliet et al., 2007) .
Previous studies have linked the brain's immune response with seizures and epilepsy, as activation of the pro-inflammatory IL-1 receptor/ Toll-like receptor (IL1R/TLR) system was shown to promote seizure onset and recurrence in mice and rats (for a review, see Devinsky
